메뉴 건너뛰기




Volumn 24, Issue 15, 2006, Pages 2397-

Importance of surgical aggressiveness in advanced ovarian cancer [7]

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

EID: 33744816219     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.0111     Document Type: Letter
Times cited : (5)

References (4)
  • 1
    • 9744223515 scopus 로고    scopus 로고
    • Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
    • Vasey PA, Jayson GC, Gordon A, et al: Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J Natl Cancer Inst 96:1682-1691, 2004
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1682-1691
    • Vasey, P.A.1    Jayson, G.C.2    Gordon, A.3
  • 2
    • 33644845467 scopus 로고    scopus 로고
    • Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial
    • Crawford SC, Vasey PA, Paul J, et al: Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial. J Clin Oncol 23:8802-8811, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8802-8811
    • Crawford, S.C.1    Vasey, P.A.2    Paul, J.3
  • 3
    • 32644455276 scopus 로고    scopus 로고
    • Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
    • Aletti GD, Dowdy SC, Gostout BS, et al: Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107:77-85, 2006
    • (2006) Obstet Gynecol , vol.107 , pp. 77-85
    • Aletti, G.D.1    Dowdy, S.C.2    Gostout, B.S.3
  • 4
    • 0034837432 scopus 로고    scopus 로고
    • Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival?
    • Eisenkop SM, Spirtos NM: Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival? Gynecol Oncol 82:435-441, 2001
    • (2001) Gynecol Oncol , vol.82 , pp. 435-441
    • Eisenkop, S.M.1    Spirtos, N.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.